Ipsen at SCOPE 2027

Mar 1–4, 2027 Orlando, FL ~5k attendees Website

Ipsen brings 3 presentations to SCOPE 2027 in Orlando. Its sessions cover faster clinical research and a new operating model for clinical development. A central question is whether trial timelines can shrink from years to months.

OrganizationSCOPE 2027 Attendance
Ipsen
Boulogne-Billancourt, France
Large pharma
Global biopharmaceutical company with marketed medicines in oncology, rare disease and neuroscience.
Talk
Tue Mar 2
8:40am–9:05am
The Other Side of Drug Development: Pharma Leader's Journey as a Rare Disease Parent
Plenary · with Decentralized Trials & Research Alliance, AlphaRose Therapeutics
Patient recruitment and engagement
Panel
Tue Mar 2
9:15am–9:45am
KEYNOTE INTERACTIVE PANEL: From Years to Months: Is Radical Acceleration in Clinical Research Finally Possible?
Plenary · with Duke Clinical Research Institute, FDA, Pfizer +2 more
Trial design and delivery
Panel
Thu Mar 4
12:20pm–12:55pm
KEYNOTE INTERACTIVE PANEL: The New Clinical Development Operating Model
Plenary · with Amgen, AstraZeneca, Regeneron
Trial design and deliveryOutsourcing and budgeting

Explore the full SCOPE 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full SCOPE 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Ipsen

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction